Analysis published on Wednesday, January 25, 2023
The action of the biotechnology company has just failed again on the resistance zone of 7.30 euros and is starting to fall again.
Technically, the situation is therefore taking a bad turn, especially since the 30-day moving average has just been pushed into slightly more sustained volumes than usual.
This deteriorated situation will encourage us to stay away as there is a great risk of experiencing a downward acceleration towards the first intermediate support zone, located at 6 euros.
The information and analyzes disseminated by ABC Bourse only constitute a decision-making aid for investors. ABC Bourse cannot be held liable directly or indirectly following the use of information and analyzes by readers. It is recommended that any uninformed person consult a professional adviser before any investment. This indicative information does not in any way constitute an incitement to sell or a solicitation to buy.